MediaPress Releases Archives Media Inquiries In the News Press Releases FEATURED PRESS RELEASE August 5, 2026Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea August 12, 2026Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central July 14, 2026Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China July 9, 2026Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine June 11, 2026Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
